DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
A•• V•••••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor not established · possible relationship
What matters now
- $100Mprincipal outstanding
$100M principal held by 2 lenders; matures Mar 2027.
Q2 2026 · Refinancing is due in 6 months at a 100¢ mark.
FactBDC schedules of investments, 30 Jun 2026; a sum of the BDCs' pieces, a lower bound
Mark path, consensus per quarter end
101¢ · 101¢ · 101¢ · 101¢ · 100¢Q2 2025 to Q2 2026
Where each lender marks it, 1 points apart
100¢101¢
Principal held
at least $100M
sum of BDC pieces, a lower bound
Fair value
$100M
100c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
2
0 equity pieces beside them
Next maturity
Mar 27, 2027
$100M inside 24 months
On the tape since
Jun 30, 2024
latest Jun 30, 2026
Events
10
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| B••• C•••••• S•••••••• F••••••• I••• | $60.3M | 100¢ | 0 pts |
| B••• C•••••• P•••••• C••••• | $40M | 101¢ | 0 pts |
Every BDC piece · 10 positions across 2 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| B••• C•••••• S•••••••• F••••••• I••• | delayed draw term loan first lien F•••• L••• S••••• S•••••• L••• - D•••••• D••• S••• F•••• 1.00% S••••• 5.90% I••••••• R••• | $41.4M | $41.4M 101c | SOFR+590 bp |
| B••• C•••••• P•••••• C••••• | delayed draw term loan first lien F•••• L••• S••••• S•••••• L••• - D•••••• D••• S••• F•••• 1.00% S••••• 5.90% I••••••• R••• | $12.9M | $12.9M 101c | SOFR+590 bp |
| B••• C•••••• S•••••••• F••••••• I••• | delayed draw term loan first lien F•••• L••• S••••• S•••••• L••• - D•••••• D••• S••• F•••• 1.00% S••••• 5.90% I••••••• R••• | $10.1M | $10.1M 99c | SOFR+590 bp |
| B••• C•••••• P•••••• C••••• | term loan first lien F•••• L••• S••••• S•••••• L••• S••• F•••• 1.00% S••••• 5.90% I••••••• R••• 9.63% M••••••• | $9.8M | $9.8M 101c | SOFR+590 bp |
| B••• C•••••• S•••••••• F••••••• I••• | delayed draw term loan first lien F•••• L••• S••••• S•••••• L••• - D•••••• D••• S••• F•••• 1.00% S••••• 5.90% I••••••• R••• | $8.3M | $8.3M 99c | SOFR+590 bp |
View all 10 positionsShow fewerlargest principal first
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| B••• C•••••• P•••••• C••••• | delayed draw term loan first lien F•••• L••• S••••• S•••••• L••• - D•••••• D••• S••• F•••• 1.00% S••••• 5.90% I••••••• R••• | $7.5M | $7.5M 101c | SOFR+590 bp |
| B••• C•••••• P•••••• C••••• | delayed draw term loan first lien F•••• L••• S••••• S•••••• L••• - D•••••• D••• S••• F•••• 1.00% S••••• 5.90% I••••••• R••• | $4.9M | $4.9M 100c | SOFR+590 bp |
| B••• C•••••• P•••••• C••••• | delayed draw term loan first lien F•••• L••• S••••• S•••••• L••• - D•••••• D••• S••• F•••• 1.00% S••••• 5.90% I••••••• R••• | $2.5M | $2.5M 100c | SOFR+590 bp |
| B••• C•••••• P•••••• C••••• | delayed draw term loan first lien F•••• L••• S••••• S•••••• L••• - D•••••• D••• S••• F•••• 1.00% S••••• 5.90% I••••••• R••• | $2.5M | $2.5M 101c | SOFR+590 bp |
| B••• C•••••• S•••••••• F••••••• I••• | term loan first lien F•••• L••• S••••• S•••••• L••• S••• F•••• 1.00% S••••• 5.90% I••••••• R••• 9.63% M••••••• | $441,000 | $441,000 97c | SOFR+590 bp |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien delayed draw term loan first lien | at least $90.2M | 100c | SOFR+590 bp | Mar 27, 2027 | 2 |
| first lien term loan first lien | at least $10.2M | 100c | SOFR+590 bp | Mar 27, 2027 | 2 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 2 | $100M | $100M | 100c | 0 |
| Mar 31, 2026 | 2 | $118M | $118M | 101c | 0 |
| Dec 31, 2025 | 2 | $115M | $115M | 101c | 0 |
| Sep 30, 2025 | 2 | $99.4M | $99.4M | 101c | 0 |
All 9 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2025 | 2 | $88.8M | $88.8M | 101c | 0 |
| Mar 31, 2025 | 2 | $61.6M | $61.6M | 102c | 0 |
| Dec 31, 2024 | 2 | $52.6M | $52.6M | 102c | 0 |
| Sep 30, 2024 | 2 | $45.4M | $45.4M | 101c | 0 |
| Jun 30, 2024 | 2 | $18.2M | $18.2M | 105c | 0 |
What changed
- Maturity approachingMar 27, 2027
- Maturity approachingMar 27, 2027
- Maturity approachingMar 27, 2027
- Maturity approachingMar 27, 2027
- Maturity approachingMar 27, 2027
Full timeline · 16 eventsShow fewer
- Maturity approachingMar 27, 2027
- Maturity extended (observed)Mar 31, 2025
- Maturity extended (observed)Mar 31, 2025
- Maturity extended (observed)Mar 31, 2025
- Maturity extended (observed)Dec 31, 2024
- Maturity extended (observed)Dec 31, 2024
- Maturity shortened (observed)Dec 31, 2024
- Maturity extended (observed)Dec 31, 2024
- Maturity extended (observed)Sep 30, 2024
- Maturity extended (observed)Sep 30, 2024
- New borrower on a BDC scheduleJun 30, 2024
Sponsor
Possible relationship, not established: R•••• C•••••• G••••• L••, because a company of this name is on the sponsor's portfolio page (confidence 0.7). No deal announcement or filing names it as a party, so it is not shown as this borrower’s sponsor.
- R•••• C•••••• G••••• L••
- the sponsor's own portfolio page lists a company of this nameestimatedriatacapital.com"••• Locked"
Identity
- Group key
- A•• V•••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 2 BDCsderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it